Evervital Lifesciences

Evervital Lifesciences is an Indian pharmaceutical company headquartered in Ahmedabad, specializing in the Nephrology, Central Nervous System (CNS), and Critical Care therapeutic segments. Established in 2022, the company provides a comprehensive portfolio of WHO-GMP certified specialty formulations, including its flagship products Cret-low for kidney health and Appitral (megestrol acetate) for appetite stimulation. The company serves patients across 16 Indian states through a robust distribution network and a dedicated professional field force. Evervital focuses on addressing complex conditions such as chronic kidney disease, diabetic nephropathy, and neurological disorders through high-quality drug formulations. With significant commercial success in its early years, the company reported annual sales of approximately ₹720 million for the 2024-2025 fiscal year. Evervital continues to expand its reach in the specialty medicine market, aiming to be a trusted partner for healthcare professionals and patients alike.